Peytant Solutions, Inc.
Plymouth, MN · CIK 0001652372 · Medtech · Private
AMStent System - a biocompatible airway stent for pulmonary obstruction treatment
peytant.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.6M
- 4 Form D · Feb 2023
- 44 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $576,504 | |
| Private capital raised | Form D · SEC | $860,000 | |
| Private capital raised | Form D · SEC | $275,005 | |
| Private capital raised | Form D · SEC | $900,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1050 | INFORMUTA, INC. | — | — |
| 1051 | ASC Newcastle LLC | — | $13M |
| 1052 | NEONEUR LLC | — | — |
| 1053 | Peytant Solutions, Inc. | — | $2.6M |
| 1054 | MILLION MARKER WELLNESS INC. | — | — |
| 1055 | BIOMED CONSULTING, INC. | — | — |
| 1056 | INOVODEL, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Clay AnselmoDirector
- Jeffrey ChambersDirector
- Bruce FaulkenDirector
- Steven HealyDirector
- James NessExecutive Officer
- John SchorglDirector · Executive Officer · Promoter
- Craig WalkerDirector
Patents
- Methods For Forming Stents Modified With Material Comprising Amnion Tissuegranted
- Delivery Of Amnion Tissue Graft With Temporary Supportapplication
- Stents Modified With Material Comprising Amnion Tissue And Corresponding Processesapplication
- Delivery Of Amnion Tissue Graft With Temporary Supportapplication
- Stents Modified With Material Comprising Amnion Tissue And Corresponding Processesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.